• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Heinz Maier Leibnitz Prize for Jennifer Andexer

Bioengineer by Bioengineer
March 27, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Photo: Thomas Kunz

Junior professor Dr. Jennifer Andexer from the Institute of Pharmaceutical Sciences at the University of Freiburg has received the Heinz Maier Leibnitz Prize 2018, which the selection committee from the German Research Foundation (DFG) and the Federal Ministry of Education and Research recently selected. Considered the most important award for junior scientists in Germany, the prize is endowed with 20,000 euros each and was awarded ten times this year. 140 researchers from all disciplines were nominated.

Jennifer Andexer has been junior professor for pharmaceutical and medicinal chemistry at the University of Freiburg since 2011. Her field of research is enzymes: proteins that catalyze chemical reactions in organisms. They are found in many everyday products – be it as an additive in detergents or in lactose-free dairy products. In biotechnology, enzymes are used as environmentally friendly catalysts to produce various substances. In addition, Andexer deals with so-called cofactors, which are necessary for certain enzymes to act as catalysts. In 2016, for example, she received a starting grant from the European Research Council (ERC) worth 1.5 million euros for her research. In her ERC-funded project, she intends to develop methods to efficiently use enzymes that depend on a particular cofactor, which is of interest for the biotechnological production of medicine and flavors for the food industry.

###

DFG press release http://www.dfg.de/service/presse/pressemitteilungen/2018/pressemitteilung_nr_11/index.html

For more information on Jennifer Andexer http://www.pharmazeutische-chemie.uni-freiburg.de/de/andexer/andexer_home

Article in the University of Freiburg online magazine on Jennifer Andexer's ERC-funded research project http://www.pr.uni-freiburg.de/pm/online-magazin/forschen-und-entdecken/magische-molekuele

Contact:

Institute of Pharmaceutical Sciences
University of Freiburg

Media Contact

Junior Professor Dr. Jennifer Andexer
[email protected]
49-761-203-67398

Startseite

Original Source

https://www.pr.uni-freiburg.de/pm-en/personalia-en/heinz-maier-leibnitz-prize-for-jennifer-andexer?set_language=en

Share13Tweet8Share2ShareShareShare2

Related Posts

Epstein-Barr Virus Protein EBNA1 Drives Oncogene Activation in Cervical Cancer Cells

Epstein-Barr Virus Protein EBNA1 Drives Oncogene Activation in Cervical Cancer Cells

August 22, 2025
APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

August 22, 2025

Metabolic Modeling Reveals Yeast Diversity for Enhanced Industrial Biotechnology

August 22, 2025

Mechanisms of Amino Acid Transport in Plants Unveiled

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Biomimetic Magnetobots Revolutionize Pneumonia Treatment

ERBB3 Drives Ferroptosis by Altering Lipids in Cancer

University of Ottawa Enters the Betavoltaic Battery Commercialization Arena

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.